Clinical Trial Update: BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 window-of-opportunity trial assesses preoperative low-dose azacitidine in high-risk early-stage breast cancer; the study is currently in the recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Breast Cancer Invasive, Early-stage Breast Cancer | Phase 2 | Status: RECRUITING